IC
Inscription Capital Portfolio holdings
AUM
$694M
This Quarter Return
+5.92%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$881M
AUM Growth
+$588M
(+201%)
Cap. Flow
+$574M
Cap. Flow
% of AUM
65.2%
Top 10 Holdings %
Top 10 Hldgs %
39.4%
Holding
403
New
211
Increased
71
Reduced
29
Closed
92
Top Buys
| 1 |
Vanguard Growth ETF
VUG
|
$51.4M |
| 2 |
JPMorgan Chase
JPM
|
$49.6M |
| 3 |
Omega Flex
OFLX
|
$44.9M |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
$44.4M |
| 5 |
Apple
AAPL
|
$37.8M |
Top Sells
Sector Composition
| 1 | Technology | 15.15% |
| 2 | Industrials | 13.72% |
| 3 | Financials | 12.06% |
| 4 | Healthcare | 9.37% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Hologic
HOLX
$14.8B
| $367K | 0.04% |
+5,500
| New | +$367K |
|
227
B&G Foods
BGS
$374M
| $366K | 0.04% |
+11,160
| New | +$366K |
|
228
iShares Russell 1000 ETF
IWB
$43.4B
| $361K | 0.04% |
+1,493
| New | +$361K |
|
229
Vanguard FTSE Emerging Markets ETF
VWO
$97.2B
| $355K | 0.04% |
6,537
-44,910
| -87% | -$2.44M |
|
230
Dell
DELL
$84.4B
| $353K | 0.04% |
+6,988
| New | +$353K |
|
231
Syndax Pharmaceuticals
SNDX
$1.47B
| $352K | 0.04% |
+20,500
| New | +$352K |
|
232
Lumen
LUMN
$4.87B
| $346K | 0.04% |
+25,490
| New | +$346K |
|
233
Hershey
HSY
$37.6B
| $344K | 0.04% |
1,976
-194
| -9% | -$33.8K |
|
|
UMPQ
234
DELISTED
Umpqua Holdings Corp
UMPQ
| $344K | 0.04% |
+18,625
| New | +$344K |
|
235
Carlyle Group
CG
$23.1B
| $335K | 0.04% |
+7,200
| New | +$335K |
|
236
Crown Castle
CCI
$41.9B
| $334K | 0.04% |
+1,710
| New | +$334K |
|
237
Linde
LIN
$220B
| $334K | 0.04% |
+1,155
| New | +$334K |
|
238
Intuitive Surgical
ISRG
$167B
| $328K | 0.04% |
+1,071
| New | +$328K |
|
239
SPDR S&P Biotech ETF
XBI
$5.39B
| $328K | 0.04% |
+2,422
| New | +$328K |
|
|
PARA
240
DELISTED
Paramount Global Class B
PARA
| $327K | 0.04% |
+7,230
| New | +$327K |
|
241
iShares Russell 1000 Value ETF
IWD
$63.5B
| $326K | 0.04% |
+2,057
| New | +$326K |
|
|
ALXN
242
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $326K | 0.04% |
+1,772
| New | +$326K |
|
243
Consolidated Edison
ED
$35.4B
| $325K | 0.04% |
4,530
+430
| +10% | +$30.9K |
|
244
Hercules Capital
HTGC
$3.49B
| $324K | 0.04% |
+18,975
| New | +$324K |
|
245
Sabra Healthcare REIT
SBRA
$4.56B
| $322K | 0.04% |
+17,675
| New | +$322K |
|
246
H&R Block
HRB
$6.85B
| $318K | 0.04% |
+13,540
| New | +$318K |
|
247
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $318K | 0.04% |
+3,842
| New | +$318K |
|
248
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$54.8B
| $317K | 0.04% |
+3,339
| New | +$317K |
|
249
iShares Core S&P Small-Cap ETF
IJR
$86B
| $313K | 0.04% |
2,766
-20,924
| -88% | -$2.37M |
|
250
FTAI Aviation
FTAI
$15.8B
| $312K | 0.04% |
+10,902
| New | +$312K |
|